Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | HPGD | P15428 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | GLA | P06280 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | NQO2 | P16083 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1395756 | 0.70 | MAPT (0.33) | MAPT | |
| SCHEMBL6344164 | 0.70 | ALDH1A1 (0.41) | MAPTTSHRALDH1A1KDM4EACHE | |
| SCHEMBL1395713 | 0.70 | — | — | |
| SCHEMBL101137 | 0.70 | MAPT (0.39) | MAPTGPR3ALDH1A1HPGDKDM4E | |
| SCHEMBL1973 | 0.67 | MAPT (0.36) | MAPTTSHRGPR3ALDH1A1HPGD | |
| SCHEMBL95080 | 0.67 | GPR3 (0.38) | MAPTTSHRGPR3ALDH1A1HPGD | |
| SCHEMBL9480318 | 0.66 | MAPT (0.48) | MAPTGPR3ALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL9049 | 0.65 | MAPT (1.00) | MAPTTSHRALDH1A1HPGDKDM4E | |
| Phenazine SCHEMBL29356959 | 0.65 | MAPT (1.00) | MAPTTSHRALDH1A1HPGDKDM4E | |
| SCHEMBL9481868 | 0.64 | MAPT (0.46) | MAPTTSHRGPR3ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111465596-B | Pyridinium salt and pest control agent | 日本曹达株式会社 | 2023-09-22 | — | — | CN | claimed |
| CN-113710675-A | Fused 9-hydroxy-1, 8-dioxo-1, 3,4, 8-tetrahydro-2H-pyrido [1,2-a ] pyrazine-7-carboxamides as HIV integrase inhibitors | 亚历山大·瓦西里耶维奇·伊瓦切恩科 | 2021-11-26 | — | — | CN | claimed |
| EP-2848667-B1 | Electrochromic single and two-core viologens and optical articles containing them | ESSILOR INT (FR) | 2019-04-10 | — | — | EP | claimed |
| EP-2848668-B1 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INT (FR) | 2019-01-09 | — | — | EP | claimed |
| CN-105579549-B | Electrochromic compositions | 依视路国际公司 | 2018-12-28 | — | — | CN | claimed |
| CN-105555912-B | electrochromic composition | 依视路国际公司 | 2018-12-14 | — | — | CN | claimed |
| US-9841652-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-12-12 | — | — | US | claimed |
| EP-2848669-B1 | Electrochromic composition | ESSILOR INT (COMPAGNIE GÉNÉRALE D'OPTIQUE) (FR) | 2017-11-29 | — | — | EP | claimed |
| US-9823534-B2 | Electrochromic single and two-core viologens and optical articles containing them | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-11-21 | — | — | US | claimed |
| US-9785030-B2 | Electrochromic composition | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2017-10-10 | — | — | US | claimed |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-05-06 | — | — | US | claimed |
| EP-2159244-A1 | ANTHRACENE POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-03-03 | — | — | EP | claimed |
| EP-2147944-A1 | PYRENE POLYMER AND LUMINESCENT ELEMENT MADE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-01-27 | — | — | EP | claimed |
| US-6946207-B2 | Electroconductive device, organic electroluminescence device using the device and process for producing the electroconductive device | CANON KABUSHIKI KAISHA (JP) | 2005-09-20 | — | — | US | claimed |
| EP-1310539-B1 | Polymer compound and polymer light-emitting device using the same | SUMITOMO CHEMICAL CO (JP) | 2005-03-16 | — | — | EP | claimed |
| US-6830832-B2 | Polyanilines; strong fluorescence and large charge transporting properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-14 | — | — | US | claimed |
| US-20030165713-A1 | Polymer compound and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-09-04 | — | — | US | claimed |
| EP-1310539-A1 | Polymer compound and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-05-14 | — | — | EP | claimed |
| US-20020135292-A1 | Electroconductive device, organic electroluminescence device using the device and process for producing the electroconductive device | CANON KABUSHIKI KAISHA (JP) | 2002-09-26 | — | — | US | claimed |
| US-5081245-A | Selective antitumor agents | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-01-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | TERB1, AHR, CYP1A1 | MAPT 881/4885TSHR 3219/4885GPR3 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.